Objectives To investigate the real-world incidence of serious infections (SI), herpes zoster (HZ) and hepatitis B virus (HBV) ...
Indaptus Therapeutics, Inc. has announced the approval of new patents in China, Japan, and Israel for its Decoy platform, which involves the use of Decoy bacteria compositions aimed at treating ...
Hepatitis B virus (HBV) reactivation may occur if someone has chronic HBV, prior exposure to HBV and is undergoing treatment, or a health condition that suppresses their immune system. The hepatitis B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results